We are live on ! Find out more
BCM

Burrage Capital Management Portfolio holdings

AUM $99.7M
1-Year Est. Return 66.05%
This Fund
S&P 500
This Quarter Est. Return
+121.53%
1 Year Est. Return
+66.05%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$149M
AUM Growth
–
Cap. Flow
+$119M
Cap. Flow %
79.48%
Top 10 Hldgs %
69.97%
Holding
29
New
29
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
EPZM
Epizyme, Inc
EPZM
+$14.3M
2
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
+$9.69M
3
ANAB icon
AnaptysBio
ANAB
+$8.52M
4
PTCT icon
PTC Therapeutics
PTCT
+$8.32M
5
KIDS icon
OrthoPediatrics
KIDS
+$7.19M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 95.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLDB icon
26
Solid Biosciences
SLDB
$794M
$358K 0.24%
+5,366
New +$592K
VIRX
27
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$185K 0.12%
+15,664
New +$262K
AUTL
28
Autolus Therapeutics
AUTL
$397M
$173K 0.12%
+13,113
New +$172K
KDNY
29
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$160K 0.11%
+27,180
New +$148K
1
2

Similar funds

WCM
Weld Capital Management New York $98.8M AUM 52.83% 1-Year Est. Return
CCM
Coe Capital Management Highland Park, Illinois $106M AUM 53.24% 1-Year Est. Return
RGM
ROAM Global Management New York $117M AUM
TCM
Taal Capital Management Boston, Massachusetts $122M AUM 50.45% 1-Year Est. Return
RC
Regents Capital Hong Kong $76.8M AUM
AC
Aperimus Capital Marina Del Rey, California $62.2M AUM 47.35% 1-Year Est. Return
QVT
Quantitative Value Technologies Overland Park, Kansas $60.7M AUM
WFWM
Wechter Feldman Wealth Management Parsippany, New Jersey $143M AUM 25.17% 1-Year Est. Return

Burrage Capital Management's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Burrage Capital Management, which disclosed 29 positions worth $149M. Its ten largest holdings account for 70% of the portfolio.

Its largest position is Epizyme, Inc: 965,519 shares worth $23.8M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets.

  • Burrage Capital Management's largest Q4 2019 buy was Epizyme, Inc: 965,519 shares worth $23.8M.
  • Burrage Capital Management's ten largest holdings make up 70% of its $149M portfolio in Q4 2019.
  • Burrage Capital Management disclosed 29 positions in Q4 2019, its first 13F filing on record.

Based on Burrage Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.